Search For "bharat biotech"
Updated : 4 months, 1 week ago IST
New Delhi [India], May 12 (ANI): The Delhi government has been forced to shut down 100 vaccination sites over 17 schools that administered Bharat Biotech's COVAXIN vaccine due to a dearth of supply from the manufacturer, Delhi Deputy Chief Minister Manish Sisodia said on Wednesday.
New Delhi [India], May 12 (ANI): The Subject Expert Committee (SEC) has given a nod to Bharat Biotech's Covaxin for Phase 2 and 3 human clinical trials on children aged between two to eight years old, sources confirmed on Wednesday.
New Delhi [India], May 11 (ANI): Bharat Biotech on Tuesday informed that the firm has been supplying its COVID-19 vaccine Covaxin directly to 18 states since May 1.
Updated : 4 months, 2 weeks ago IST
Mumbai (Maharashtra) [India], May 1 (ANI): Maharashtra Deputy Chief Minister Ajit Pawar has said that the state had planned a big COVID-19 vaccination event for Saturday but has only received 3 lakh doses out of which 20,000 doses have been given to Pune district, adding that the state go
Bhopal (Madhya Pradesh) [India], April 30 (ANI): The vaccination drive against COVID-19 for people aged 18 to 45 will be not be beginning from May 1 in Madhya Pradesh as vaccines are not available, Chief Minister Shivraj Singh Chauhan informed on Thursday.
New Delhi [India], April 30 (ANI): Bharat Biotech on Thursday announced it will supply its COVID-19 vaccine--Covaxin to state governments at Rs 400 per dose.
Updated : 4 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], April 28 (ANI): The Maharashtra government has written to COVID-19 vaccine manufacturers Serum Institute of India (SII) and Bharat Biotech about the state's vaccination requirements ahead of the next phase of the inoculation drive which starts on May 1.
Hyderabad (Telangana) [India], April 24 (ANI): Covaxin, the indigenous vaccine against COVID-19 will be available for state governments at Rs 600 per dose and private hospitals at Rs 1,200 per dose, Hyderabad-based Bharat Biotech announced on Saturday.
Updated : 4 months, 4 weeks ago IST
Hyderabad (Telangana) [India], April 21 (ANI): Covaxin, India's indigenous vaccine against COVID-19 demonstrated "overall interim clinical efficacy" of 78 per cent and 100 per cent efficacy against "severe COVID-19 disease" in Phase-III trials, informed Bharat Biotech and Indian Council of M
New Delhi [India], April 21 (ANI): Indigenously-developed Covid-19 vaccine Covaxin, made by Bharat Biotech, neutralises multiple variants of SARS-CoV-2 and effectively neutralises the double mutant strain as well, the Indian Council of Medical Research (ICMR) said on Wednesday.
Updated : 5 months ago IST
New Delhi [India], April 20 (ANI): Finance Minister Nirmala Sitharaman has approved a total of Rs 4,567.50 crore as advance payment to Serum Institute of India (SII) and Bharat Biotech to ramp up vaccine production against coronavirus, sources told ANI.
New Delhi [India], April 16 (ANI): The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly 6-7 fold by July-August 2021, the government announced on Friday as the country is witnessing a record surge in COVID-19 inf